[HTML][HTML] Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of …
RAS Salman, DP Minks, D Mitra, MA Rodrigues… - The Lancet …, 2019 - thelancet.com
Background Findings from the RESTART trial suggest that starting antiplatelet therapy might
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
[PDF][PDF] Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of …
RAS Salman, DP Minks, D Mitra, MA Rodrigues… - 2019 - pure.ed.ac.uk
Background Findings from the RESTART trial suggest that starting antiplatelet therapy might
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
[HTML][HTML] Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of …
RAS Salman, DP Minks, D Mitra, MA Rodrigues… - The Lancet …, 2019 - Elsevier
Background Findings from the RESTART trial suggest that starting antiplatelet therapy might
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the …
DP Minks, D Mitra, MA Rodrigues… - The Lancet …, 2019 - europepmc.org
Background Findings from the RESTART trial suggest that starting antiplatelet therapy might
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the …
RAS Salman, DP Minks, D Mitra, MA Rodrigues… - The Lancet …, 2019 - cir.nii.ac.jp
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral
haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART …
haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART …
[PDF][PDF] Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of …
RAS Salman, DP Minks, D Mitra… - Lancet …, 2019 - services.nhslothian.scot
Background Findings from the RESTART trial suggest that starting antiplatelet therapy might
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
[PDF][PDF] Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of …
RAS Salman, DP Minks, D Mitra, MA Rodrigues… - 2019 - academia.edu
Background Findings from the RESTART trial suggest that starting antiplatelet therapy might
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: Subgroup analyses of the …
RAS Salman, DP Minks, D Mitra, MA Rodrigues… - Lancet …, 2019 - research.ed.ac.uk
Background: Findings from the RESTART trial suggest that starting antiplatelet therapy might
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the …
K Njoku - The Lancet. Neurology, 2019 - research.manchester.ac.uk
BACKGROUND: Findings from the RESTART trial suggest that starting antiplatelet therapy
might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with …
might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with …
[PDF][PDF] Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of …
RAS Salman, DP Minks, D Mitra, MA Rodrigues… - Lancet Neurol, 2019 - core.ac.uk
Background Findings from the RESTART trial suggest that starting antiplatelet therapy might
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …
reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding …